Back to Results
First PageMeta Content
Biology / Vaccines / Vaccination / Antimalarial medication / Plasmodium falciparum / NmVac4-A/C/Y/W-135 / Meningococcal disease / Medicine / Health / Malaria


WHO/IVBWHO Preferred Product Characteristics (PPC) for Malaria Vaccines
Add to Reading List

Document Date: 2015-01-26 19:04:35

Open Document

File Size: 3,82 MB

Share Result on Facebook

City

Geneva / /

Company

PSPQ / Packaging Advisory Group / /

Country

Switzerland / /

/

/

IndustryTerm

product development tool / /

MedicalCondition

highly effective second generation malaria / disease / human malaria infection / malaria / Plasmodium falciparum malaria / malaria epidemics / highly effective malaria / recombinant malaria / malaria interventions Malaria / recommended malaria / clinical malaria / generation malaria / significant malaria / vivax malaria / Vaccines preventing malaria disease / dominant malaria / severe disease / priority disease / /

MedicalTreatment

immunization / mass immunization / immunization schedules / immunizations / vaccination / chemotherapy / Chemoprophylaxis / /

Organization

Department of Immunization / Vaccines and Biologicals Ordering / Malaria Policy Advisory Committee / World Health Organization / WHO PQ / World Health Organization Department of Immunization / Malaria Vaccines DEPARTMENT OF IMMUNIZATION / Department of Immunization / Vaccines and Biologicals / Vaccine administration / /

/

Technology

diagnostic tests / chemotherapy / pdf / /

URL

http /

SocialTag